Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis

Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic acid are at risk of disease progression and need additional therapy. Obeticholic acid (OCA) was approved in Canada in May 2017, but its effectiveness in a real‐world setting has not been described. We sought...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatol Commun
Main Authors: Roberts, Surain B., Ismail, Marwa, Kanagalingam, Gowthami, Mason, Andrew L., Swain, Mark G., Vincent, Catherine, Yoshida, Eric M., Tsien, Cynthia, Flemming, Jennifer A., Janssen, Harry L.A., Hirschfield, Gideon M., Hansen, Bettina E., Gulamhusein, Aliya F.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471421/
https://ncbi.nlm.nih.gov/pubmed/32923836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1518
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados